Caroline Raffin

发表

Treg cell-based therapies: challenges and perspectives

J. Bluestone, Caroline Raffin, Linda T. Vo, 2019, Nature Reviews Immunology.

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer

D. Valmori, M. Ayyoub, I. Luescher, 2013, Haematologica.

Human Memory Helios− FOXP3+ Regulatory T Cells (Tregs) Encompass Induced Tregs That Express Aiolos and Respond to IL-1β by Downregulating Their Suppressor Functions

D. Valmori, M. Ayyoub, P. Pignon, 2013, The Journal of Immunology.

Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors

D. Valmori, M. Ayyoub, Caroline Raffin, 2010, Proceedings of the National Academy of Sciences.

Ex Vivo IL-1 Receptor Type I Expression in Human CD4+ T Cells Identifies an Early Intermediate in the Differentiation of Th17 from FOXP3+ Naive Regulatory T Cells

D. Valmori, M. Ayyoub, Caroline Raffin, 2011, The Journal of Immunology.

Intermediate in the Differentiation of Th 17 T Cells Identifies an Early + Human CD 4 Ex Vivo IL-1 Receptor Type I Expression in Maha Ayyoub

D. Valmori, M. Ayyoub, Caroline Raffin, 2011 .

CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

K. Odunsi, D. Valmori, J. Matsuzaki, 2012, Cancer research.

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28

J. Bluestone, A. Marson, Theodore L. Roth, 2020, bioRxiv.

Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis

J. Bluestone, M. Sadelain, A. Lanzavecchia, 2016, The Journal of Immunology.

Comment on “A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation”

D. Valmori, M. Ayyoub, Caroline Raffin, 2013, The Journal of Immunology.

Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors

D. Valmori, M. Ayyoub, Caroline Raffin, 2010, Proceedings of the National Academy of Sciences.

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer

D. Valmori, M. Ayyoub, I. Luescher, 2013, Haematologica.